Biomarkers and Risk Scores for Risk Stratification of Unstable Angina
Can a Multi-marker Strategy Improve Risk Stratification and Expedite Discharge in Unstable Angina? A Comparison With High Sensitive Troponin T
1 other identifier
observational
489
0 countries
N/A
Brief Summary
The main purpose of the study is to improve management and expedite safe discharge of patients presenting with chest pain with troponin ≤14ng/l using fifth generation, 'highly sensitive' troponin T. Our aim would be to specifically test in a prospective study whether biomarkers for left ventricular wall stress (NT pro brain natriuretic peptide), ischaemia (Heart-type fatty acid protein) and a novel marker of stress, raised in a number of pathological states growth differentiation factor -15, add significantly to the prognostic value of clinical information and resting ECG presenting with ischaemic sounding chest pain. The 5th generation troponin assay will be used and the range of values from 1-14ng/l will also be compared to the biomarkers studied in terms of hard cardiac endpoints. Recent studies have indicated that very low levels of detected troponin in patients with stable coronary artery disease do adversely impact on cardiac death and the development of heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2011
CompletedFirst Submitted
Initial submission to the registry
August 9, 2018
CompletedFirst Posted
Study publicly available on registry
August 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedAugust 17, 2018
August 1, 2018
7.7 years
August 9, 2018
August 15, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Major Adverse Cardiac Event: death, myocardial infarction, revascularisation
All cause death, myocardial infarction and revascularisation within 3 years of index presentation
3 years
Eligibility Criteria
1. Admission with chest pain which could be due to underlying ischaemic heart disease 2. HSTroponin T \< 15ng/L in patients with possible ischaemic sounding chest pain admitted to hospital at least 6 hours since onset of chest pain or in those with pain \<3hours since admission with no STEMI, a baseline HStroponin T \<15ng/l (time 0 on admission) and HSTroponin T \<15ng/l at 3 hours and \<20% increase compared to baseline (time 0) 3. Ability to give informed consent for extraction of blood for biochemical screening
You may qualify if:
- Patients presenting within 12 hours of chest pain thought to be cardiac in origin but with no ST segment elevation on ECG
- th generation troponin T \<15ng/l
You may not qualify if:
- Troponin positive patients, Tn T\>=15ng/lµg/l
- Diagnosis of non-cardiac chest pain made at outset
- Known History of chronic heart failure or cardiomyopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Jones J, Hughes E, Dobson R, Ashrafi R, Heseltine T, Campbell M, Collinson P, Khand A. Risk Stratification of Acute Chest Pain in Patients With High-Sensitivity Troponin T Below the 99th Percentile: A Long-Term Cohort Study Assessing the Incremental Value of Necrosis and Non-necrosis Biomarkers to Clinical Risk Scores. J Am Heart Assoc. 2025 Oct 21;14(20):e040590. doi: 10.1161/JAHA.124.040590. Epub 2025 Oct 14.
PMID: 41085181DERIVED
Biospecimen
plasma samples to allow extraction for a range of biologically plausible biomarkers associated with elevated risk in suspected acute coronary syndromes
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- consultant interventional cardiologist
Study Record Dates
First Submitted
August 9, 2018
First Posted
August 14, 2018
Study Start
January 10, 2011
Primary Completion
October 1, 2018
Study Completion
December 1, 2018
Last Updated
August 17, 2018
Record last verified: 2018-08